Every 8 hours, someone in America dies from mesothelioma. That’s roughly three people per day, every day of the year. Behind each statistic is a person—usually in their 60s or 70s—who was exposed to asbestos decades ago and is now facing a disease with one of the lowest survival rates of any cancer.
Who are these people? Where were they exposed? And why, 50 years after we first regulated asbestos, are Americans still dying from it?
The data tells a story that most people don’t know.
Need charts and graphics for presentations, articles, or social media? Visit our Data & Statistics page for downloadable SVG/PNG visualizations with embed codes. Free to use with attribution.
The Numbers at a Glance
| Metric | Number |
|---|---|
| New U.S. cases annually | 2,500-3,000 |
| Global deaths annually | ~45,000 |
| Latency period | 20-50 years |
| 5-year survival rate | 12% |
Who Gets Mesothelioma?
Mesothelioma doesn’t strike randomly. The disease has a clear demographic profile shaped by decades of occupational exposure patterns.
By Gender
| Gender | Percentage of Cases |
|---|---|
| Male | 80% |
| Female | 20% |
The gender gap reflects who worked in asbestos-heavy industries. Shipyards, construction sites, and industrial facilities were overwhelmingly male workplaces through the mid-20th century.
But the gap is narrowing. Women are increasingly diagnosed from:
- Secondary exposure: Washing work clothes contaminated with asbestos fibers
- Environmental exposure: Living near asbestos mines or processing facilities
- Cosmetic talc: Talcum powder products contaminated with asbestos
By Age
| Age Metric | Value |
|---|---|
| Average age at diagnosis | 72 years |
| Cases under age 45 | Less than 1% |
| Cases ages 65-74 | 55% |
The age distribution reflects the disease’s long latency period. People exposed in their 20s and 30s typically don’t develop symptoms until their 60s or 70s.
This delay explains why mesothelioma cases are still rising in some demographics—we’re now seeing disease from exposures that occurred in the 1970s and 1980s.
By Occupation
The highest-risk occupations account for most cases:
| Occupation | Relative Risk |
|---|---|
| Insulation workers | 46x average |
| Shipyard workers | 30x average |
| Pipefitters/Plumbers | 18x average |
| Construction workers | 10x average |
| Navy veterans | 8x average |
| Power plant workers | 6x average |
About 20% of mesothelioma cases involve no direct occupational exposure. Many of these are family members—especially wives and children—who were exposed to asbestos fibers brought home on workers’ clothing, skin, and hair.
The Veterans Crisis
One-third of all mesothelioma patients in the United States are military veterans. This isn’t coincidence—it’s the result of decades of heavy asbestos use across every branch of the armed forces.
| Veteran Metric | Value |
|---|---|
| Share of U.S. mesothelioma cases | 33% |
| Highest-risk branch | Navy |
| Years since most military exposure | 30+ |
Why Veterans?
Naval vessels: Ships built before 1980 contained thousands of pounds of asbestos in insulation, gaskets, and fireproofing. Sailors worked, ate, and slept surrounded by the material.
Military construction: Barracks, mess halls, and other facilities were built with asbestos-containing materials. Renovation and demolition exposed countless service members.
Combat equipment: Tanks, aircraft, and vehicles used asbestos in brake systems, gaskets, and heat shields.
No warnings: Unlike some civilian workplaces, military personnel were rarely informed of asbestos risks or provided with protective equipment.
Veterans exposed in the 1960s and 1970s are now reaching the age when mesothelioma typically appears. The VA expects cases to continue rising through 2030.
Geographic Hot Spots
Mesothelioma isn’t evenly distributed across the country. Cases cluster around areas with histories of shipbuilding, heavy industry, and asbestos manufacturing.
Highest-rate states:
- Maine (shipyards)
- West Virginia (industrial)
- Wyoming (mining, oil & gas)
- Pennsylvania (steel mills, shipyards)
- Washington (shipyards, Boeing)
Highest-rate cities:
- Hampton Roads, Virginia (naval shipyards)
- Seattle-Tacoma (shipyards, Boeing)
- Philadelphia (shipyards, industrial)
- Los Angeles/Long Beach (ports, shipyards)
The small town of Libby, Montana has mesothelioma rates 40-60 times the national average due to a vermiculite mine contaminated with asbestos that operated until 1990. Over 400 residents have died from asbestos-related diseases.
The Survival Reality
Mesothelioma has one of the lowest survival rates of any cancer. The statistics are stark:
| Stage at Diagnosis | Median Survival |
|---|---|
| Stage 1 (localized) | 22 months |
| Stage 2 | 19 months |
| Stage 3 | 16 months |
| Stage 4 (distant) | 14 months |
Why so low?
- Most cases are diagnosed at advanced stages (symptoms appear late)
- The cancer is resistant to standard chemotherapy
- Surgery is only possible for a minority of patients
- The patient population skews older with more comorbidities
However, there’s reason for cautious optimism. New immunotherapy combinations have improved survival for some patients, and clinical trials are showing promising results.
The Cost of Mesothelioma
| Cost Metric | Amount |
|---|---|
| Average annual treatment | $150,000+ |
| Lifetime treatment cost | $500,000-$1M |
| Trust fund payouts to date | $30+ billion |
Beyond direct medical costs, mesothelioma creates massive economic impact through:
- Lost wages and productivity
- Caregiver burden (many patients require full-time care)
- Legal and administrative costs
- Long-term disability
Trends: Is It Getting Better?
The answer is complicated.
Good news: Mesothelioma rates in younger age groups are declining, reflecting reduced asbestos exposure since regulations began in the 1970s.
Bad news: Overall cases haven’t decreased significantly because we’re still seeing disease from exposures that occurred 30-50 years ago. The CDC projects cases will remain elevated through at least 2030.
Concerning trend: Cases linked to non-occupational exposure (environmental, secondary, cosmetic talc) appear to be increasing as a proportion of total cases.
What Happens Next?
Mesothelioma will remain a significant public health problem for decades:
- Existing exposure: Millions of Americans were exposed before regulations. Many will develop disease.
- Legacy asbestos: Older buildings, ships, and infrastructure still contain asbestos. Renovation and demolition continue to expose workers.
- Global trade: Asbestos is still mined and used in countries that export products to the U.S.
- Climate disasters: Hurricanes, wildfires, and floods damage buildings and release asbestos into communities.
The 3,000 Americans who will die from mesothelioma this year were exposed decades ago. The decisions we make now about asbestos in schools, homes, and workplaces will determine how many die in 2050.
Related Reading
How many people die from mesothelioma each year?▼
Approximately 2,500-3,000 Americans die from mesothelioma annually. Globally, the number is around 45,000. Cases are expected to remain elevated through at least 2030 due to the disease’s 20-50 year latency period.
Who is most at risk for mesothelioma?▼
The highest-risk groups are military veterans (especially Navy), construction workers, shipyard workers, insulation workers, and industrial tradespeople. Men account for 80% of cases, and the average age at diagnosis is 72. Family members of workers can also be at risk from take-home exposure.
Why are mesothelioma cases still occurring if asbestos is regulated?▼
Mesothelioma has a latency period of 20-50 years between exposure and diagnosis. People exposed in the 1970s and 1980s are now developing the disease. Additionally, asbestos remains in millions of older buildings, and some countries still produce and export asbestos products.
What is the survival rate for mesothelioma?▼
The overall 5-year survival rate is approximately 12%. However, outcomes vary significantly based on stage at diagnosis, cell type, patient health, and treatment. Some patients with early-stage disease who receive aggressive treatment survive significantly longer.